MedPath

Liminal BioSciences Ltd.

🇬🇧United Kingdom
Ownership
Subsidiary
Employees
-
Market Cap
-
Website
http://www.liminalbiosciences.com

Clinical Trials

10

Active:0
Completed:5

Trial Phases

2 Phases

Phase 1:4
Phase 2:6

Drug Approvals

0

Drug Approvals

No drug approvals found

This company may not have drug approvals in our database

Clinical Trials

Distribution across different clinical trial phases (10 trials with phase data)• Click on a phase to view related trials

Phase 2
6 (60.0%)
Phase 1
4 (40.0%)

A Healthy Volunteer Study to Compare Fezagepras (PBI-4050) With Sodium Phenylbutyrate

Phase 1
Terminated
Conditions
Hyperammonemia
Interventions
First Posted Date
2022-04-27
Last Posted Date
2022-08-01
Lead Sponsor
Liminal BioSciences Ltd.
Target Recruit Count
8
Registration Number
NCT05349435
Locations
🇬🇧

Celerion, Belfast, Northern Ireland, United Kingdom

A Healthy Volunteer Study of PBI-4050

Phase 1
Completed
Conditions
Fibrosis
Inflammation
Interventions
Drug: PBI-4050/ Placebo
First Posted Date
2021-01-05
Last Posted Date
2021-11-30
Lead Sponsor
Liminal BioSciences Ltd.
Target Recruit Count
65
Registration Number
NCT04695041
Locations
🇬🇧

Covance CRU, Ltd., Leeds, United Kingdom

Single Ascending Dose Study of PBI-4547 in Healthy Subjects

Phase 1
Terminated
Conditions
Healthy Subjects
Interventions
Other: Placebo
First Posted Date
2019-08-28
Last Posted Date
2020-12-08
Lead Sponsor
Liminal BioSciences Ltd.
Target Recruit Count
24
Registration Number
NCT04068259
Locations
🇨🇦

Syneos Health, Québec, Canada

Effect of PBI-4050 on the Pharmacokinetics of Midazolam in Heathy Adult Subjects

Phase 1
Completed
Conditions
Healthy
Interventions
First Posted Date
2018-08-17
Last Posted Date
2020-12-08
Lead Sponsor
Liminal BioSciences Ltd.
Target Recruit Count
22
Registration Number
NCT03637049
Locations
🇺🇸

Celerion, Tempe, Arizona, United States

Open-Label Rollover Study of PBI 4050 in Subjects With Alström Syndrome

Phase 2
Terminated
Conditions
Alström Syndrome
Interventions
First Posted Date
2017-06-12
Last Posted Date
2020-11-03
Lead Sponsor
Liminal BioSciences Ltd.
Target Recruit Count
10
Registration Number
NCT03184584
Locations
🇬🇧

University Hospitals Birmingham NHS Foundation Trus, Birmingham, United Kingdom

  • Prev
  • 1
  • 2
  • Next

News

No news found
© Copyright 2025. All Rights Reserved by MedPath